Northwestern Mutual Wealth Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History
Bought
Maintained
Sold
Northwestern Mutual Wealth Management's AST.WS Position: Q3 2017 in Review
Northwestern Mutual Wealth Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 1 share.
Northwestern Mutual Wealth Management first reported a position in AST.WS in Q1 2017 and held it in 2 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.
- Northwestern Mutual Wealth Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 1 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) share in Q3 2017.
- Northwestern Mutual Wealth Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q1 2017 and held it in 2 quarters.
- Northwestern Mutual Wealth Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
- 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2017, filed 7 Nov 2017.